NCT06969924 Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
| NCT ID | NCT06969924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Leiden University Medical Center |
| Condition | Adult Congenital Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2014-01-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2014-01-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.
Eligibility Criteria
Inclusion Criteria: * ACHD patients who underwent CRT implantation Exclusion Criteria: * Less than 18 years old on the moment of CRT implantation * Patient objection to the use of retrospective data
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06969924 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Adult Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06969924 currently recruiting?
Yes, NCT06969924 is actively recruiting participants. Contact the research team at a.egorova@lumc.nl for enrollment information.
Where is the NCT06969924 trial being conducted?
This trial is being conducted at Leiden, Netherlands.
Who is sponsoring the NCT06969924 clinical trial?
NCT06969924 is sponsored by Leiden University Medical Center. The trial plans to enroll 100 participants.